Immunovia AB (publ) announced appointment of Nomination Committee for the 2023 Annual General Meeting . Based on the above, the Nomination Committee for the 2023 Annual General Meeting has been determined to consist of the following persons who together represent 13.46% of the number of shares and votes in the company as of September 30, 2022: Ranny Davidoff, representing Ranny Davidoff Carl Borrebaeck, Chairman of the Board, Peter Lindvall representing Mikael Löfman; and Mats Leifland, representing Mats Ohlin.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.416 SEK | -1.12% | +4.12% | -20.09% |
21/05 | Immunovia Seeks SEK70 Million from Proposed Rights Offering | MT |
29/04 | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 |
1st Jan change | Capi. | |
---|---|---|
-20.09% | 6.09M | |
-27.64% | 16.31B | |
-39.76% | 2.93B | |
+14.84% | 1.82B | |
-8.11% | 1.53B | |
+31.19% | 1.29B | |
-17.64% | 949M | |
-27.00% | 835M | |
+7.22% | 809M | |
-26.00% | 611M |
- Stock Market
- Equities
- IMMNOV Stock
- News Immunovia AB
- Immunovia AB Announces Appointment of Nomination Committee for the 2023 Annual General Meeting